Study of Efficacy and Safety of Ginger Extract Compared With Loratadine for Treatment of Allergic Rhinitis

Rhinitis,Allergic Clinical Trial

Official title:
Comparative Study of Efficacy and Adverse Effects of Ginger Extract and Loratadine for Treatment of Allergic Rhinitis Patients (Clinical Trial Phase II)

Status Completed

Clinical Trial Summary

Efficacy and adverse effects of Ginger extract in treating allergic rhinitis patients compared with Loratadine.The double blind randomized controlled trial study was approved by the Human Research Ethics Committee of Thammasat University NO.1.

Clinical Trial Description

The double blind randomized controlled trial study. Patients who meet the inclusion criteria and do not fall into any exclusion criteria will be randomly placed into the experimental group, who will receive ginger extract capsules, or the control group, who will receive loratadine for 42 days. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02576808
Study type	Interventional
Source	Thai Traditional Medical Knowledge Fund
Contact
Status	Completed
Phase	Phase 2
Start date	October 2015
Completion date	October 2017

View Details

See also
	Status	Clinical Trial	Phase
	Completed	`NCT02885025` - Effects of Broccoli Sprout Extract on Allergy Rhinitis	Phase 2
	Terminated	`NCT02953106` - Effects of Intranasal Fluticasone Plus Azelastine on Airway Inflammation in Patients With Asthma & Allergic Rhinitis	Phase 4